Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
North Texas Gynecologic Oncology is a Dallas-based gynecologic oncology and women’s health specialty practice providing surgical and medical care for gynecologic cancers and complex benign gynecologic conditions. The practice offers cancer surgery, systemic chemotherapy, intraperitoneal chemotherapy, immuno-oncologic and targeted therapies, HIPEC, hereditary cancer management, and robotic-assisted gynecologic surgery. It also provides services for pelvic reconstructive surgery, abnormal Pap smear management, and MonaLisa Touch laser treatments for selected vaginal and vulvar conditions. Public materials indicate the practice operates as an active clinical provider rather than a drug-development biotech company, and it appears to function in association with or as a division of The Center for Cancer and Blood Disorders in North Texas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North Texas Gynecologic Oncology.